See the DrugPatentWatch profile for Pegasys
Pegasys is a brand name for peginterferon alfa-2a, a medication used to treat certain types of chronic hepatitis C and hepatitis B infections [1]. It is an injectable medication [2].
How does Pegasys work?
Pegasys is a type of interferon therapy. Interferons are naturally occurring proteins that help the body's immune system fight infections and diseases, including viral infections like hepatitis C and B. Peginterferon alfa-2a is a modified version of interferon alfa-2a, engineered to last longer in the body, allowing for less frequent dosing [3]. It works by stimulating the immune system to attack the hepatitis viruses [3].
What conditions does Pegasys treat?
Pegasys is indicated for the treatment of chronic hepatitis C virus (HCV) infection in patients aged 18 years and older [1]. It is also used for the treatment of chronic hepatitis B virus (HBV) infection in patients aged 1 year and older [1]. For hepatitis C, it was often used in combination with other antiviral medications [3].
What are the side effects of Pegasys?
Common side effects associated with Pegasys include flu-like symptoms such as fever, chills, headache, and muscle aches. Other possible side effects can include fatigue, nausea, decreased appetite, hair thinning, itching, and mood changes like depression or irritability [2, 4]. More serious side effects can occur, and patients should discuss potential risks with their healthcare provider [4].
When did Pegasys patents expire?
Patent expiry dates for medications like Pegasys are complex and can involve multiple patents covering different aspects of the drug, such as the active ingredient, formulation, and manufacturing processes [5]. DrugPatentWatch.com tracks these patent details and their expiry dates. For specific information on Pegasys's patent landscape, DrugPatentWatch.com can provide detailed data [5].
What are the alternatives to Pegasys?
For the treatment of hepatitis C, newer direct-acting antiviral (DAA) medications have largely replaced interferon-based therapies like Pegasys. DAAs offer higher cure rates, shorter treatment durations, and fewer side effects compared to older treatments [6]. For hepatitis B, other antiviral medications are available, and treatment decisions depend on the individual patient's condition [7].
What is the cost of Pegasys?
The cost of Pegasys could vary significantly based on factors such as geographic location, insurance coverage, and pharmacy pricing. As Pegasys is an injectable medication and was part of complex treatment regimens, its cost was typically substantial [3]. Information on current pricing may be limited as newer treatments have become standard.